Welcome!

News Feed Item

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

http://www.reportlinker.com/p01041701/Parenteral-Nutrition-Market-to-201...

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

Summary

EuropeGermanyFranceItalySpainJapan

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The PN market is rapidly growing with the increasing incidence of diseases such as cancer, AIDS and GI disorders including short bowel syndrome, ischemic bowel disease, pseudo obstruction and Crohn's disease. The other major factor driving growth of the PN market is an increase in the elderly population in the developed countries. In 2011, the global PN market was estimated to be worth $2.9 billion, representing a CAGR of 6.3% between 2004 and 2011. The US market, with sales worth $1,476m in 2011, accounted for 50.7% of the total PN market. The market in the top five countries in Europe was estimated to be $1,275m, the second largest PN market, and to have grown at a CAGR of 5.4% between 2004 and 2011. The PN market in Japan registered a share of 5.4% of the total PN market, accounting for $157m sales value in 2011.

By 2018, the PN market is forecast to be worth $4,861m, representing a CAGR of 7.6% between 2011 and 2018. The US is expected to remain the largest segment in the PN market with $2,492m of sales in 2018. The PN market in the top five countries in Europe will be the second largest segment with $2,104m in revenues in 2018. Japan, which was the smallest segment in 2011, is expected to register sales value of $265m in 2018, indicating a CAGR of 7.8% between 2011 and 2018. The PN market M&A landscape demonstrated a fairly moderate level of activity between 2004 and 2010, with seven major acquisition deals signed during the time period.

Scope

- Annualized market data for the PN market from 2004 to 2011, forecast forward to 2018.- Analysis of the PN market in the leading geographies of the world, which include the US, the top five countries in Europe (the UK, Germany, France, Italy, Spain) and Japan. - Market segmentation of the PN market which includes the amino acid, lipids, carbohydrates and additives market in the leading geographies.- Key drivers and barriers that have a significant impact on the market. - Competitive benchmarking of the leading companies. The key companies studied in this report are Baxter, B. Braun, Fresenius Kabi, Hospira, Otsuka Pharmaceutical Factory, Terumo Corporation and Ajinomoto.- Key M&A activities, licensing agreements that have taken place between 2004 and 2011 in the global PN market.

Reasons to buy

- Develop market-entry and market expansion strategies by identifying the leading geographic markets poised for strong growth.- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class products with more efficiency and better safety.- Develop key strategic initiatives by understanding the key focus areas of leading companies. - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.1 Table of Contents1 Table of Contents 51.1 List of Tables 71.2 List of Figures 82 Parenteral Nutrition Market to 2018 - Introduction 93 Parenteral Nutrition Market to 2018 - Overview 103.1 Clinical Nutrition 103.1.1 Enteral Nutrition 113.1.2 Parenteral Nutrition 114 Parenteral Nutrition Market to 2018 - Market Characterization and Forecasts 154.1 Revenue Forecasts 154.2 Parenteral Nutrition Market Drivers 164.2.1 Increase in the Incidence of Diseases such as Cancer, AIDS and GI Disorders that Require Nutrition Support 174.2.2 Increase in the Elderly Population will Drive PN Market Growth 174.2.3 The Home Parenteral Nutrition Sector will Witness Strong Market Growth 174.3 Parenteral Nutrition Market Restraints 174.3.1 Reimbursement Regulations will Hinder Market Growth in the US 174.3.2 Increasing Preference for Enteral Nutrition will Restrain Market Growth 174.3.3 Increasing Preference for Multi-chamber Bags Decreases Cost of Therapy 185 Parenteral Nutrition Market to 2018 - Geographical Landscape 195.1 Revenues by Geographical Segmentation 195.2 The US 215.2.1 Sales Value 215.2.2 Nutrient Market Segmentation 225.2.3 Key Products 225.3 Top Five Countries in Europe 235.3.1 Sales Value 235.3.2 Nutrient Market Segmentation 245.3.3 Key Products 245.4 Japan 255.4.1 Sales Value 255.4.2 Nutrient Market Segmentation 265.4.3 Key Products 266 Parenteral Nutrition Market to 2018 - Nutrient Market Segmentation 276.1 Overview 276.2 Amino Acids Market 286.2.1 Global Sales Value 286.2.2 Sales Value by Geography 286.3 Lipids Market 296.3.1 Global Sales Value 296.3.2 Sales Value by Geography 296.4 Carbohydrates Market 306.4.1 Global Sales Value 306.4.2 Sales Value by Geography 306.5 Additives Market 316.5.1 Global Sales Value 316.5.2 Sales Value by Geography 317 Parenteral Nutrition Market - Marketed Products 327.1 Baxter International Inc. 327.1.1 OLIMEL 327.1.2 Clinimix 337.1.3 ClinOleic 20% 347.1.4 Clinisol 15% 357.2 B. Braun Melsungen AG 367.2.1 NuTRIflex System 367.2.2 Lipofundin 377.2.3 Aminoplasmal 387.2.4 FreAmine III 397.3 Fresenius Kabi AG 407.3.1 Intralipid 407.3.2 SmofKabiven 417.3.3 Dipeptiven 427.3.4 Omegaven 437.4 Hospira, Inc. 447.4.1 Aminosyn 447.4.2 Liposyn 467.5 Otsuka Pharmaceutical Factory Inc. 477.5.1 Elneopa 477.5.2 Neoparen 477.5.3 B-Fluid 487.6 Terumo Corporation 497.6.1 Unicaliq 497.6.2 Fulcaliq 508 Parenteral Nutrition Market to 2018 - Competitive Landscape 518.1 Market Share Analysis: Parenteral Nutrition 518.2 Competitive Profiling 528.2.1 Baxter International Inc. 528.2.2 B. Braun Melsungen AG 548.2.3 Fresenius Kabi AG 568.2.4 Hospira, Inc. 588.2.5 Otsuka Pharmaceutical Factory Inc. 608.2.6 Terumo Corporation 619 Parenteral Nutrition Market to 2018 - Strategic Consolidations 629.1 Overview 629.2 Major Acquisitions in the Parenteral Nutrition Market 639.2.1 Baxter International Completes Acquisition of Prism Pharma for $338m in April 2011 639.2.2 Baxter Acquires Willow Healthcare Services in July 2009 639.2.3 Fresenius Acquires Novartis Nutrition and Nestle Espana in December 2007 639.2.4 Fresenius Kabi Acquires Infusia A.S. in December 2004 639.2.5 Fresenius Kabi Acquires Clinico GmbH in October 2005 639.2.6 Fresenius Kabi Acquires Isotec Nutrition from Alliance Pharmaceuticals in May 2004 639.2.7 Hospira Acquires Clayton Manufacturing Facility from Fresenius Kabi in June 2004 639.3 Major Agreements in the Parenteral Nutrition Market 649.3.1 Baxter Signs Agreement with Hanmi Pharmaceuticals in December 2010 649.3.2 Hospira Signs a Five-year Agreement with Novation in October 2010 649.3.3 B. Braun Signs Agreement with Amerinet Inc in October 2009 649.3.4 B. Braun Signs Agreement with Premier Purchasing Partners in August 2008 649.3.5 Hospira Announces New Contract with Premier Purchasing Partners in August 2008 659.3.6 Hospira Announces New Contract with HealthTrust Purchasing Group in February 2008 659.3.7 Baxter and Novation Sign Two-year Contract Extension in October 2007 659.3.8 Baxter Announces Plans to Form Parenteral Nutrition Joint Venture with Baiyunshan in China in August 2007 659.3.9 B. Braun Signs Agreement with Curlin Medical in March 2006 659.3.10 Fresenius Kabi and Pharmatel Pty Ltd. Formed a Joint Venture in September 2004 6610 Parenteral Nutrition Market to 2018 - Appendix 6710.1 Market Definitions 6710.2 Abbreviations 6710.3 Bibliography 6810.4 Research Methodology 6910.4.1 Coverage 6910.4.2 Secondary Research 6910.4.3 Primary Research 6910.4.4 Section Methodology 7010.4.5 Expert Panel Validation 7010.5 Contact Us 7010.6 Disclaimer 70

1.1 List of Tables

Table 1: Parenteral Nutrition Market, Global, Nutritional Status Assessment, 2011 10Table 2: Parenteral Nutrition Market, The US, A.S.P.E.N. Guidelines for Parenteral Nutrition, 2004 13Table 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2011 15Table 4: Parenteral Nutrition Market, Global, Revenue Forecasts ($m), 2011-2018 15Table 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 19Table 6: Parenteral Nutrition Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 20Table 7: Parenteral Nutrition Market, The US, Revenues ($m), 2004-2011 21Table 8: Parenteral Nutrition Market, The US, Revenue Forecasts ($m), 2011-2018 21Table 9: Parenteral Nutrition Market, Top Five Countries of Europe, Revenues ($m), 2004-2011 23Table 10: Parenteral Nutrition Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018 23Table 11: Parenteral Nutrition Market, Japan, Revenues ($m), 2004-2011 25Table 12: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2011-2018 25Table 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation ($m), 2011 28Table 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 2011 29Table 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation ($m), 2011 30Table 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m), 2011 31Table 17: Parenteral Nutrition Market, Global, Product Composition - Lipofundin, 2012 37Table 18: Parenteral Nutrition Market, Global, Product Composition - Aminoplasmal, 2012 38Table 19: Parenteral Nutrition Market, Global, Product Composition - Aminosyn, 2012 45Table 20: Parenteral Nutrition Market, Global, Strategic Consolidations Overview, 2012 62

1.2 List of Figures

Figure 1: Parenteral Nutrition Market, Global, Nutritional Support Algorithm 11Figure 2: Parenteral Nutrition Market, Global, Nutrition Requirements for TPN, 2012 12Figure 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2018 15Figure 4: Parenteral Nutrition Market, Global, Drivers and Barriers, 2012 16Figure 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m), 2004-2018 19Figure 6: Parenteral Nutrition Market, The US, Historic Revenue and Forecasts ($m), 2004-2018 21Figure 7: Parenteral Nutrition Market, The US, Key Products, 2012 22Figure 8: Parenteral Nutrition Market, Top Five Countries of Europe, Historic Revenue and Forecasts ($m), 2004-2018 23Figure 9: Parenteral Nutrition Market, Top Five Countries in Europe, Key Products, 2011 24Figure 10: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2004-2018 25Figure 11: Parenteral Nutrition Market, Japan, Key Products, 2011 26Figure 12: Parenteral Nutrition Market, Global, Nutrient Market Segmentation (%), 2011 27Figure 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation ($m), 2011 28Figure 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 2011 29Figure 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation ($m), 2011 30Figure 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m), 2011 31Figure 17: Parenteral Nutrition Market, Global, Product Profile - OLIMEL, 2012 32Figure 18: Parenteral Nutrition Market, Global, Product Profile - Clinimix, 2012 33Figure 19: Parenteral Nutrition Market, Global, Product Profile - ClinOleic 20%, 2012 34Figure 20: Parenteral Nutrition Market, Global, Product Profile - Clinisol 15%, 2012 35Figure 21: Parenteral Nutrition Market, Global, Product Profile - NuTRIflex, 2012 36Figure 22: Parenteral Nutrition Market, Global, Product Profile - Lipofundin, 2012 37Figure 23: Parenteral Nutrition Market, Global, Product Profile - Aminoplasmal, 2012 38Figure 24: Parenteral Nutrition Market, Global, Product Profile - FreAmine III, 2012 39Figure 25: Parenteral Nutrition Market, Global, Product Profile-Intralipid, 2012 40Figure 26: Parenteral Nutrition Market, Global, Product Profile - SmofKabiven, 2012 41Figure 27: Parenteral Nutrition Market, Global, Product Profile - Dipeptiven, 2012 42Figure 28: Parenteral Nutrition Market, Global, Product Profile - Omegaven, 2012 43Figure 29: Parenteral Nutrition Market, Global, Product Profile - Aminosyn, 2012 44Figure 30: Parenteral Nutrition Market, Global, Product Profile - Liposyn, 2012 46Figure 31: Parenteral Nutrition Market, Global, Product Profile - Neoparen, 2012 47Figure 32: Parenteral Nutrition Market, Global, Product Profile - B-Fluid, 2012 48Figure 33: Parenteral Nutrition Market, Global, Product Profile - Unicaliq, 2012 49Figure 34: Parenteral Nutrition Market, Global, Product Profile - Fulcaliq, 2012 50Figure 35: Parenteral Nutrition Market, Global, Market Share of Top Manufacturers (%), 2011 51Figure 36: Parenteral Nutrition Market to 2018, Global, Company Profile - Baxter International Inc., 2012 52Figure 37: Parenteral Nutrition Market, Global, SWOT Analysis - Baxter International Inc., 2012 53Figure 38: Parenteral Nutrition Market to 2018, Global, Company Profile - B. Braun Melsungen AG, 2012 54Figure 39: Parenteral Nutrition Market, Global, SWOT Analysis - B. Braun Melsungen AG, 2012 55Figure 40: Parenteral Nutrition Market, Global, Company Profile - Fresenius Kabi AG, 2012 56Figure 41: Parenteral Nutrition Market, Global, SWOT Analysis - Fresenius Kabi AG, 2012 57Figure 42: Parenteral Nutrition Market, Global, Company Profile - Hospira Inc., 2012 58Figure 43: Parenteral Nutrition Market, Global, SWOT Analysis - Hospira Inc., 2012 59Figure 44: Parenteral Nutrition Market, Global, Company Profile - Otsuka Pharmaceutical Factory Inc., 2012 60Figure 45: Parenteral Nutrition Market, Global, Company Profile - Terumo Corporation, 2012 61Figure 46: Parenteral Nutrition Market, Global, Strategic Consolidations Overview (%), 2012 62

Companies mentioned

Baxter International Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Hospira, Inc.

Otsuka Pharmaceutical Factory Inc.

Terumo Corporation

To order this report:Pharmaceutical Industry: Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

Nicolas Bombourg
Reportlinker
Email:
[email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive ad...
"We are an all-flash array storage provider but our focus has been on VM-aware storage specifically for virtualized applications," stated Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
With all the incredible momentum behind the Internet of Things (IoT) industry, it is easy to forget that not a single CEO wakes up and wonders if “my IoT is broken.” What they wonder is if they are making the right decisions to do all they can to increase revenue, decrease costs, and improve customer experience – effectively the same challenges they have always had in growing their business. The exciting thing about the IoT industry is now these decisions can be better, faster, and smarter. Now ...